Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Mass Balance of ONO-5788 in Healthy Men
NCT03849872Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ONO-5788 in acromegaly (2 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Absolute bioavailability of ONO-5788 in plasma at 72 hours and Mass balance of ONO-5788 up to 42 days. Started Feb 2019; status: completed.
02
Drugs
ONO-5788
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT03849872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849872.